Kazerifimab, AstraZeneca, and sutrovimab provided

"Abu Dhabi Health" tackles "Corona" with the latest 3 drugs in the world

The Department of Health in Abu Dhabi, the regulator of the health care sector in the Emirate of Abu Dhabi, has provided three drugs to treat and prevent the “Covid-19” virus, as part of its continuous efforts to ensure the health and safety of members of society, which qualified it to be at the forefront of the classification of leading cities around the world in Response to the COVID-19 pandemic.

In detail, the Abu Dhabi Department of Health confirmed its continuation of its exceptional response and leadership, as part of global efforts to combat and contain the "Covid-19" pandemic, to improve health care services in the emirate, by strengthening important global partnerships, which contribute to attracting and using the latest innovations and treatment solutions that supplement the efforts of The distinguished response to the pandemic in Abu Dhabi, and contributes to ensuring the health and safety of community members.

The department indicated that it has provided the drug "Roche" (caserifimab and imdivimab), which works to prevent corona virus, and treat patients with mild and moderate cases in the emirate, pointing out that the drug "Roche" consists of a mixture of antibodies consisting of the drugs "caserifimab" and "Roche". "Imdivimab", is able to treat people infected with the virus and prevent disease.

The department indicated that the drug has approval from the European Union and Japan, conditional approval in the United Kingdom and Australia, and is approved for emergency use in a number of countries in the world, including the United States of America, India, Switzerland and Canada, and it is also one of the drugs recommended by the World Health Organization for the treatment of “Covid-19”, pointing out that “Roche” is the largest company in the world in the field of biotechnology, and it has a distinguished group of drugs in the fields of oncology, immunology, infectious diseases, ophthalmology, and central nervous system diseases.

The department provided the drug "AstraZeneca AZD7442", thus making the UAE, and after obtaining the necessary use approvals, among the first countries to use this drug that generates antibodies for patients with weak immunity.

And she indicated that “AZD7442” is the first long-acting drug based on antibodies, which has proven through clinical trials in the third phase to provide prevention and treatment from “Covid-19” disease, and to protect those who are still at risk, despite obtaining the vaccine, and the drug has been developed The new and innovative drug to prevent infection and reduce deaths in patients who are most at risk of complications and who are not vaccinated, pointing out that the drug "AZD7442" will give new hope to patients with various immune disorders, who were unable to receive the vaccine.

The department has also established a network of supply chains through the Rafid Company, to facilitate the process of providing AstraZeneca (AZD7442) and distributing it through the Rafid Company Distribution Center, which is the largest and most advanced facility for low-temperature storage in the region.

In addition to the drugs “Cazerivimab”, “Emdivimab”, and AstraZeneca (AZD7442), Abu Dhabi was the first city in the world to receive last June a shipment of the drug “Sutrovimab”, which is intended to treat infection with the “Covid-19” virus, becoming the first city in the world to receive The new treatment.

Sotrovimab is the latest drug in the world to treat certain cases of people infected with the “Covid-19” virus, and it contains monoclonal antibodies, given intravenously, and can be used to treat adults and children over 12 years of age, who meet certain criteria and are at risk. The development of severe “Covid-19” symptoms in them, according to the protocols developed by the National Scientific Committee, where studies have shown that the drug prevents the disease from developing to severe cases or death in more than 85% of early treatment cases.

The effective and distinguished response of the Emirate of Abu Dhabi revolves around the health and safety of community members, as this is based on strengthening joint efforts with the most prominent local and international pharmaceutical companies since the beginning of the pandemic.

Abu Dhabi tops the world rankings

The Department of Health in Abu Dhabi confirmed the emirate's continued efforts to maintain its leading position in the world in terms of flexibility and safety in the time of the pandemic, by continuing its daily preventive efforts for research and evaluation, and identifying sources and areas of local and international cooperation, to obtain the best medical solutions for members of society in Abu Dhabi, the UAE and abroad.

The new drug is one of the most prominent advanced achievements in the pharmaceutical industry, and it constitutes an effective tool to limit the spread of the emerging corona virus.

These achievements contribute to strengthening Abu Dhabi's leading position in responding to the pandemic, and continuing to lead the world in responding to the pandemic, especially as it ranked first among 50 leading cities around the world, according to the latest classification issued by the "Deep Knowledge Group" based in London, which confirms the leadership of the health sector. .

• Important global partnerships to attract and use the latest innovations and treatment solutions.

Follow our latest local and sports news and the latest political and economic developments via Google news